Biovista and FDA to Collaborate on a Medication Safety Initiative

Biovista Inc. Tuesday announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects.
Earth Times